Allergan Won’t Seek Further Foothold in Ireland, CEO Pyott Says

Allergan Inc. Chief Executive Officer David Pyott said he probably won’t follow other drugmakers in making an acquisition in Ireland as a way to lower the company’s corporate taxes.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.